Nanobiotix Statistics

Total Valuation

Nanobiotix has a market cap or net worth of $163.94 million. The enterprise value is $165.23 million.

Market Cap	163.94M
Enterprise Value	165.23M

Important Dates

The last earnings date was Wednesday, April 2, 2025, after market close.

Earnings Date	Apr 2, 2025
Ex-Dividend Date	n/a

Share Statistics

Nanobiotix has 47.40 million shares outstanding. The number of shares has increased by 27.99% in one year.

Current Share Class	n/a
Shares Outstanding	47.40M
Shares Change (YoY)	+27.99%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	20.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	-22.02
Forward PS	4.77
PB Ratio	-2.41
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.04

Current Ratio	1.04
Quick Ratio	0.98
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.44

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-52.89%
Return on Invested Capital (ROIC)	-251.54%
Return on Capital Employed (ROCE)	-804.64%
Revenue Per Employee	n/a
Profits Per Employee	-$653,123
Employee Count	108
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Nanobiotix has paid $104,566 in taxes.

Income Tax	104,566
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.60% in the last 52 weeks. The beta is 1.55, so Nanobiotix's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	-48.60%
50-Day Moving Average	3.37
200-Day Moving Average	4.00
Relative Strength Index (RSI)	51.97
Average Volume (20 Days)	7,645

Short Selling Information

Short Interest	4,755
Short Previous Month	9,524
Short % of Shares Out	0.01%
Short % of Float	0.02%
Short Ratio (days to cover)	0.47

Income Statement

In the last 12 months, Nanobiotix had revenue of -$7.44 million and -$70.54 million in losses. Loss per share was -$1.49.

Revenue	-7.44M
Gross Profit	-7.44M
Operating Income	-70.67M
Pretax Income	-43.27M
Net Income	-70.54M
EBITDA	-70.05M
EBIT	-70.67M
Loss Per Share	-$1.49

Full Income Statement

Balance Sheet

The company has $51.49 million in cash and $52.70 million in debt, giving a net cash position of -$1.21 million or -$0.03 per share.

Cash & Cash Equivalents	51.49M
Total Debt	52.70M
Net Cash	-1.21M
Net Cash Per Share	-$0.03
Equity (Book Value)	-68.02M
Book Value Per Share	-1.43
Working Capital	2.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$20.24 million and capital expenditures -$875,867, giving a free cash flow of -$22.65 million.

Operating Cash Flow	-20.24M
Capital Expenditures	-875,867
Free Cash Flow	-22.65M
FCF Per Share	-$0.48

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	949.35%
Pretax Margin	946.19%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.99%
Shareholder Yield	-27.99%
Earnings Yield	-43.03%
FCF Yield	-13.81%

Analyst Forecast

The average price target for Nanobiotix is $8.00, which is 140.24% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	140.24%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nanobiotix has an Altman Z-Score of -3.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.73
Piotroski F-Score	1